作者：
José Luis,García-Giménez [1]
;
Eva,García-López [2]
;
Salvador,Mena-Mollá [3]
;
Jesús,Beltrán-García [4]
;
Rebeca,Osca-Verdegal [5]
;
Elena,Nacher-Sendra [6]
;
Carmen,Aguado-Velasco [7]
;
Germán,Casabó-Vallés [4]
;
Carlos,Romá-Mateo [7]
;
María,Rodriguez-Gimillo [6]
;
Oreto,Antúnez [8]
;
José,Ferreres [4]
;
Federico V,Pallardó [7]
;
Nieves,Carbonell [6]
作者单位：
Center for Biomedical Research Network On Rare Diseases (CIBERER), Carlos III Health Institute, Valencia, Spain. j.luis.garcia@uv.es.
[1]
INCLIVA Biomedical Research Institute, Valencia, Spain. j.luis.garcia@uv.es.
[2]
Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain. j.luis.garcia@uv.es.
[3]
Center for Biomedical Research Network On Rare Diseases (CIBERER), Carlos III Health Institute, Valencia, Spain.
[4]
EpiDisease S.L. (Spin-Off CIBER-ISCIII), Parc Científic de la Universitat de València, Paterna, Valencia, Spain.
[5]
Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.
[6]
INCLIVA Biomedical Research Institute, Valencia, Spain.
[7]
Department of Medicine, University of California San Diego, La Jolla, CA, USA.
[8]
Intensive Care Unit, Clinical University Hospital of Valencia (HCUV), Valencia, Spain.
[9]
Proteomics Unit, SCSIE-University of Valencia, Burjassot, València, Spain.
[10]
INCLIVA Biomedical Research Institute, Valencia, Spain. edurnecarbonell@yahoo.es.
[11]
Intensive Care Unit, Clinical University Hospital of Valencia (HCUV), Valencia, Spain. edurnecarbonell@yahoo.es.
[12]
DOI
10.1186/s12967-023-04197-1
PMID
37221624
发布时间
2023-05-26
换一批
换一批
